docetaxel,darolutamide
bayer
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'arasens', ' daro ']
arasens: dosing, safety, &amp; pharmacokinetics of daro + adt + doce #gu23 mdot: daro (41.0 mo) vs pbo (16.7 mo) more daro pts (45.9% vs 19.1%) still receiving rx pts requiring doce dose modification: daro (60.0%) vs pbo (62.9%) doce plasma conc 
Uro Onc @GACancerCenter | Res PD & Ronald W. Lewis MD Chair of Uro Educ @mcg_urology | Digital Media Ed @EUplatinum | #mentalhealth research | @urotoday